Cell Signaling Technology

TRBP2 (D7C8K) Rabbit Monoclonal Antibody

#62043 · $161,351

15

Citing papers

1.1k

Combined citations

Supplier page Find this product

Research areas

Sarcoma Diagnosis and Treatment10 Angiogenesis and VEGF in Cancer3 Vascular Tumors and Angiosarcomas3 Cardiac tumors and thrombi3 Beetle Biology and Toxicology Studies2 PI3K/AKT/mTOR signaling in cancer2 Melanoma and MAPK Pathways2 Peptidase Inhibition and Analysis2

Papers citing this product

1

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

Journal of Clinical Oncology·2009·573 cit.·DOI

2

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

Journal of Clinical Oncology·2011·247 cit.·DOI

3

Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery

Molecular Cancer Therapeutics·2010·107 cit.·DOI

4

The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives

Current Treatment Options in Oncology·2021·57 cit.·DOI

5

Frequent amplification of receptor tyrosine kinase genes in well-differentiated/ dedifferentiated liposarcoma

Oncotarget·2017·41 cit.·DOI

6

A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas

British Journal of Cancer·2015·37 cit.·DOI

7

Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes

Cancer Research·2017·35 cit.·DOI

8

The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models

PLoS ONE·2011·19 cit.·DOI

9

Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma

Cancers·2019·13 cit.·DOI

10

Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma

Sarcoma·2016·10 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.